RAL+ATV/r in Comparison With TDF/FTC (or 3TC) +ATV/r in HIV Infected Patients

NCT01829802 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Chronic Infection With HIV

Interventions

DRUG: Ritonavir boosted Atazanavir
DRUG: Raltegravir
DRUG: TDF/FTC (or 3TC)

Sponsor

Pedro Cahn

Collaborators

[object Object]